Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$10.24 - $17.57 $73,728 - $126,504
-7,200 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$6.2 - $12.0 $44,640 - $86,400
7,200 New
7,200 $84,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Barometer Capital Management Inc. Portfolio

Follow Barometer Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barometer Capital Management Inc. with notifications on news.